slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 6,601-6,630
Pages 395
Rows per page 30
Slide function
6,601-6,630 of 11,828
27
The chart uses stacked bars to show geographic segmentation of users over time.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
28
The slide uses two bar charts side-by-side to demonstrate consistent revenue growth over different timeframes.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
The slide shows two distinct bar charts side-by-side representing annual and quarterly ARPU trends.Nextdoor | Investor Presentation Deck | 34 slides · Nextdoor
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
06
The slide uses a logo grid to establish credibility and market presence.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
08
The slide details a capital raise structure involving senior secured notes and warrants.NextNav | Investor Presentation Deck | 10 slides · NextNav
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
04
The slide combines a retrospective traction report with a mission/vision statement.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
19
The chart displays dose-dependent exposure levels exceeding multiple efficacy targets (ROS1 G2032R and Wild Type in CNS and periphery).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
20
Clinical trial data presentation for NVL-520.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
21
The chart uses a waterfall plot to visualize clinical efficacy, a standard in oncology drug development.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
22
The chart is a swimmer plot (a common clinical trial visualization).Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
23
Includes clinical trial data (ORR, tumor shrinkage, allele clearance) for a specific drug candidate.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
24
Includes patient case study images and clinical trial metrics.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations Beat · TractionLoop · Day In Life1 hit
31
The slide compares vehicle control against NVL-655 treatment in both bar chart (multiple models) and line chart (PDX model) formats.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
09
The slide demonstrates superior tumor volume reduction by NXP800 compared to standard-of-care Cisplatin in both SKOV-3 and TOV-21G models.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Includes a patient-derived xenograft (PDX) study workflow diagram and a tumor volume growth curve.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The chart shows tumor volume reduction over 28 days compared to vehicle control.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The charts demonstrate efficacy in specific cell lines (KYSE70 and Cal27) with known genetic alterations.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Includes citation references and a 'Newly published' callout for the Abington Hospital study.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
12
Includes logos for UChicago Medicine and Lenox Hill Hospital/Northwell Health.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
14
Slide features a press release excerpt detailing the partnership.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
17
Includes a testimonial from a NICU nurse practitioner.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
18
The slide highlights high survival rates, particularly in the <10kg group which traditionally receives no therapy.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
23
Includes a 'Growth Agenda' list and financial status indicators (cash/debt).Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Beat · Financials1 hit
28
Includes a callout box at the bottom summarizing strategic goals.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations 1 hit
06
The slide uses two pie charts to illustrate the expansion of the pipeline over time.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
07
Includes footnotes defining active partners and active programs.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
08
OmniAb | Investor Presentation Deck | 35 slidesOmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
The chart shows a steady increase in clinical programs from 2016 to mid-2023.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The slide uses a column-based layout to track progress for specific drug programs (Batoclimab, IMVT-1402, CSX-1004, APVO436, GSK Program-1).OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
24
Includes a phylogenetic-style radial diagram of ion channel families.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Loop · Cost Of Inaction1 hit